News Releases Year: All News20182017201620152014 Items per page All News2550 Summary ToggleContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates Summary Toggle June 18, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States Summary Toggle June 14, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record Summary Toggle June 12, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering Summary Toggle June 5, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals’ Cyclophilin Inhibitor, CRV431, Reduces Liver Fibrosis in a Preclinical Model Summary Toggle May 31, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals’ Cyclophilin Inhibitor, CRV431, Reduces Development and Progression of Liver Tumors in Preclinical Hepatocellular Carcinoma Study Summary Toggle May 30, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals to Present at 2018 BIO International Convention Summary Toggle May 29, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split Summary Toggle May 24, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Announces New Data Presented at the 2018 International Liver Congress™ Summary Toggle April 12, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board Summary Toggle April 9, 2018 View News Release > Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
